BioSpace News Archive

Inteliquet, a leading provider of intelligent technology, insights, and services for optimizing clinical trials and research, announced today that it has hired Jean Roberson, CPA, as Chief Financial Officer (CFO).

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Karen Dahut to its Board of Directors, effective immediately.

Provides additional options to help meet increased demand for continuous renal replacement therapy (CRRT) products resulting from COVID-19 pandemic Most recent example of Baxter’s efforts to increase supply of dialysis products used in an acute care environment DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S.

PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer though the selective modulation of oncogene translation, today announced the appointment of Katherine Bowdish, Ph.D., as its President and Chief Executive Officer. Dr. Bowdish will also join the Board of Directors of PIC. Dr. Bowdish brings more than 20 years of biopharmaceutical business and scientific leadership to PIC

A patient’s school not requiring the Meningitis B (MenB) vaccine was the most frequent reason why healthcare providers did not discuss the vaccine with their 16-to-23-year-old patients, according to an online survey conducted among 524 healthcare providers by the Meningitis B Action Projec

At a recent Board of Directors meeting, updated Mission, Vision and Values statements for the American Society for Reproductive Medicine were adopted.

The Charlotte R. Schmidlapp Fund, Fifth Third Bank, Trustee, has gifted Cincinnati Children’s Hospital Medical Center with $1.66 million to permanently endow the Charlotte R. Schmidlapp Science, Technology, Engineering and Mathematics Scholars program.

Company’s StudyTeam platform harmonizes biopharma and research site workflows, introducing a new paradigm for clinical research that brings therapies to patients sooner BOSTON--( BUSINESS WIRE )-- Reify Health , provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced a $30 million Series B funding round led by Battery Ventures. Reify developed its platform, StudyTeam, to upgrade the systems th

bioAffinity Technologies , a privately held biotech company advancing cutting-edge cancer diagnostics, and Precision Pathology Services , a CAP/CLIA-certified anatomic and clinical pathology laboratory, announced initiation of CLIA validation for CyPath® Lung, a non-invasive flow

Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the appointment of Kevin N. Heller, M.D., as Executive Vice President, Research & Development. In this newly created role, Dr. Heller will lead the Company’s clinical and research functions and oversee clinical development, clinical strategy and operations, medical affairs and early research and